Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Cancer
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Research article

Validation of Quality of Life Instruments for Cancer Patients – Colorectal Cancer (QLICP-CR) in patients with colorectal cancer in Northeast China

Authors: Min Liu, Wei Sun, Yuan-Yi Cai, Hua-Zhang Wu

Published in: BMC Cancer | Issue 1/2018

Login to get access

Abstract

Background

Measuring quality of life is important for cancer patients, but there are regional differences in age-standardized colorectal cancer incidence and mortality rates which may affect measurement. This study aimed to evaluate the reliability, validity and responsiveness of Quality of Life Instruments for Cancer Patients – Colorectal Cancer (QLICP-CR) in colorectal cancer patients in Northeast China, and assess its usefulness for evaluation of quality of life in these patients.

Methods

From November 2016 to January 2017, 152 patients with colorectal cancer from Liaoning Cancer Hospital & Institute were surveyed three times using QLICP-CR and the Functional Assessment of Cancer Therapy – Colorectal (FACT-C) to measure their quality of life (on admission, 2–3 days later and at discharge). Reliability was evaluated by internal consistency and test–retest reliability. Validity was examined by item–domain correlation, criterion-related validity and factor construct validity analysis. Responsiveness was assessed using paired Student’s t tests and calculating standardized response mean.

Results

Cronbach’s α coefficient for QLICP-CR ranged from 0.62 to 0.93. Pearson correlation and intra-class correlation coefficients for QLICP-GM, the five domains and the total scale of QLICP-CR ranged from 0.74 to 0.91 and 0.74 to 0.90. The item–domain correlation analysis showed good convergent validity and discriminant validity. Correlation analysis of domain scores between FACT-C and QLICP-CR showed good criterion-related validity. Exploratory factor analysis revealed that nine and three principal components were extracted from items in the two modules of QLICP-CR, and the contribution rate of cumulative variance was 70.21 and 72.26%. There were significant differences in quality of life between the first and the third measurements, with standardized response mean values ranging from 0.30 to 0.81.

Conclusions

The QLICP-CR was a reliable, valid and sensitive instrument to measure quality of life in colorectal cancer patients in Northeast China.
Literature
1.
Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.CrossRefPubMed
2.
Zhang J, Wang X, de Voer RM, Hehir-Kwa JY, Kamping EJ, Weren RDA, et al. A molecular inversion probe-based next-generation sequencing panel to detect germline mutations in Chinese early-onset colorectal cancer patients. Oncotarget. 2017;8(15):24533–47.PubMedCentralPubMed
3.
Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32.CrossRefPubMed
4.
Stiggelbout AM, Kunneman M, Baas-Thijssen MC, Neijenhuis PA, Loor AK, Jagers S, et al. The EORTC QLQ-CR29 quality of life questionnaire for colorectal cancer: validation of the Dutch version. Qual Life Res. 2016;25(7):1853–8.CrossRefPubMed
5.
Parry C, Kent EE, Mariotto AB, Alfano CM, Rowland JH. Cancer survivors: a booming population. Cancer Epidemiol Biomark Prev. 2011;20(10):1996–2005.CrossRef
6.
Roekel EHV, Winkler EAH, Bours MJL, Lynch BM, Willems PJB, Meijer K, et al. Associations of sedentary time and patterns of sedentary time accumulation with health-related quality of life in colorectal cancer survivors. Prev Med Rep. 2016;4:262–9.CrossRefPubMedCentralPubMed
7.
Bours MJ, van der Linden BW, Winkels RM, van Duijnhoven FJ, Mols F, van Roekel EH, et al. Candidate predictors of health-related quality of life of colorectal Cancer survivors: a systematic review. Oncologist. 2016;21(4):433–52.CrossRefPubMedCentralPubMed
8.
Polat U, Arpacı A, Demir S, Erdal S, Yalcin S. Evaluation of quality of life and anxiety and depression levels in patients receiving chemotherapy for colorectal cancer: impact of patient education before treatment initiation. J Gastrointest Oncol. 2014;5(4):270–5.PubMedCentralPubMed
9.
Braun DP, Gupta D, Grutsch JF, Staren ED. Can changes in health related quality of life scores predict survival in stages III and IV colorectal cancer? Health Qual Life Outcomes. 2011;9(1):62–9.CrossRefPubMedCentralPubMed
10.
Adams SV, Ceballos R, Newcomb PA. Quality of life and mortality of long-term colorectal Cancer survivors in the Seattle colorectal Cancer family registry. PLoS One. 2016;11(6):e0156534.CrossRefPubMedCentralPubMed
11.
Xu C, Yang Z, Tan J, Meng Q, Cun Y, Tang X, et al. Development and validation of the system of quality of life instruments for cancer patients: colorectal cancer (QLICP-CR). Cancer Investig. 2012;30(10):732–40.CrossRef
12.
Van REH, Bours MJL, Breedveld-Peters JJL, Willems PJB, Kenneth M, Ijmert K, et al. Modeling how substitution of sedentary behavior with standing or physical activity is associated with health-related quality of life in colorectal cancer survivors. Cancer Causes Control. 2016;27(4):513–25.CrossRef
13.
Caravatijouvenceaux A, Launoy G, Klein D, Henryamar M, Abeilard E, Danzon A, et al. Health-related quality of life among long-term survivors of colorectal Cancer: a population-based study. Oncologist. 2011;16(11):1626–36.CrossRef
14.
Thraenborowski KM, Trenthamdietz A, Edwards DF, Koltyn KF, Colbert LH. Dose-response relationships between physical activity, social participation, and health-related quality of life in colorectal cancer survivors. J Cancer Surviv. 2013;7(3):369–78.CrossRef
15.
Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–76.CrossRefPubMed
16.
Sprangers MA, te Velde A, Aaronson NK. The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European organization for research and treatment of cancer study group on quality of life. Eur J Cancer. 1999;35(2):238–47.CrossRefPubMed
17.
Whistance RN, Conroy T, Chie W, Costantini A, Sezer O, Koller M, et al. Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer. Eur J Cancer. 2009;45(17):3017–26.CrossRefPubMed
18.
Wong CKH, Lam CLK, Brendan M, Wai-Lun L, Poon JTC, Kwong DLW, et al. Measurement invariance of the functional assessment of Cancer therapy-colorectal quality-of-life instrument among modes of administration. Qual Life Res. 2013;22(6):1415–26.CrossRefPubMed
19.
Yoo HJ, Kim JC, Eremenco S, Han OS. Quality of life in colorectal cancer patients with colectomy and the validation of the functional assessment of Cancer therapy-colorectal (FACT-C), version 4. J Pain Symptom Manag. 2005;30(1):24–32.CrossRef
20.
Wan C, Meng Q, Yang Z, Tu X, Feng C, Tang X, et al. Validation of the simplified Chinese version of EORTC QLQ-C30 from the measurements of five types of inpatients with cancer. Ann Oncol. 2008;19(12):2053–60.CrossRefPubMedCentralPubMed
21.
Lin JB, Zhang L, Wu DW, Xi ZH, Wang XJ, Lin YS, et al. Validation of the chinese version of the EORTC QLQ-CR29 in patients with colorectal cancer. World J Gastroentero. 2017;23(10):1891–8.CrossRef
22.
Wong CK, Lam CL, Law WL, Poon JT, Chan P, Kwong DL, et al. Validity and reliability study on traditional Chinese FACT-C in Chinese patients with colorectal neoplasm. J Eval Clin Pract. 2012;18(6):1186–95.CrossRefPubMed
23.
Wan C, Yang Z, Meng Q, Feng C, Wang H, Tang X, et al. Development and validation of the general module of the system of quality of life instruments for cancer patient. Int J Cancer. 2008;122(1):190–6.CrossRefPubMed
24.
Chen W, Zheng R, Zhang S, Zeng H, Xia C, Zuo T, et al. Cancer incidence and mortality in China, 2013. Cancer Lett. 2017;401:63–71.CrossRefPubMed
25.
Zhao X, Li H, Sun C. The regional cultural map in China: is it“the great unification”or“the diversification”? Management World. 2015;2:101–19.
26.
Xu Q. Local dietetic customs in the Northeast reflected in er ren zhuan. J Res Diet Sci Cult. 2014;31(2):9–14.
27.
Ma P. The influence of geographical environment upon dietetic culture differences between the north and the south in China: a case study of guanzhong of Shanxi and southeast of Guizhou. J Kaili University. 2010;28(1):128–32.
28.
Xu X. Research on differences of food catering culture between the south and the north. Hum Resour Manag. 2017;7:300–1.
29.
Yusof AS, Isa ZM, Shah SA. Dietary patterns and risk of colorectal cancer: a systematic review of cohort studies (2000–2011). Asian Pac J Cancer Prev. 2012;13(9):4713–7.CrossRefPubMed
30.
Menezes RFD, Bergmann A, Aguiar SSD, Thuler LC. Alcohol consumption and the risk of cancer in Brazil: a study involving 203,506 cancer patients. Alcohol. 2015;49(7):747–51.CrossRefPubMed
31.
Fischer MJ, Inoue K, Matsuda A, Kroep JR, Nagai S, Tozuka K, et al. Cross-cultural comparison of breast cancer patients' quality of life in the Netherlands and Japan. Breast Cancer ResTreat. 2017;166(2):459–71.CrossRef
32.
Peng J, Shi D, Goodman KA, Goldstein D, Xiao C, Guan Z, et al. Early results of quality of life for curatively treated rectal cancers in Chinese patients with EORTC QLQ-CR29. Radiat Oncol. 2011;6(1):93.CrossRefPubMedCentralPubMed
33.
Nair CK, George PS, Rethnamma KS, Bhargavan R, Abdul Rahman S, Mathew AP, et al. Factors affecting health related quality of life of rectal cancer patients undergoing surgery. Indian J Surg Oncol. 2014;5(4):266–73.CrossRefPubMedCentralPubMed
34.
Thaysen HV, Jess P, Laurberg S, Groenvold M. Validation of the Danish version of the disease specific instrument EORTC QLQ-CR38 to assess health-related quality of life in patients with colorectal cancer. Health Qual Life Outcomes. 2012;10(1):150–9.CrossRefPubMedCentralPubMed
35.
Zhou HJ, So JB, Yong WP, Luo N, Zhu F, Naidoo N, et al. Validation of the functional assessment of cancer therapy-gastric module for the Chinese population. Health Qual Life Outcomes. 2012;10(1):145–52.CrossRefPubMedCentralPubMed
36.
Colwell HH, Mathias SD, Turner MP, Lu J, Wright N, Peeters M, et al. Psychometric evaluation of the FACT colorectal Cancer symptom index (FCSI-9): reliability, validity, responsiveness, and clinical meaningfulness. Oncologist. 2010;15(3):308–16.CrossRefPubMedCentralPubMed
37.
Gerhardsson L, Gillström L, Hagberg M. Test-retest reliability of neurophysiological tests of hand-arm vibration syndrome in vibration exposed workers and unexposed referents. J Occup Med Toxicol. 2014;9(1):38–43.CrossRefPubMedCentralPubMed
38.
Wheelwright S, Darlington AS, Fitzsimmons D, Fayers P, Arraras JI, Bonnetain F, et al. International validation of the EORTC QLQ-ELD14 questionnaire for assessment of health-related quality of life elderly patients with cancer. Brit J Cancer. 2013;109(4):852–8.CrossRefPubMedPubMedCentral
39.
Smith AB, Wright P, Selby PJ, Velikova GA. Rasch and factor analysis of the functional assessment of Cancer therapy-general (FACT-G). Health Qual Life Outcomes. 2007;5(1):19–29.CrossRefPubMedCentralPubMed
40.
Uwer L, Rotonda C, Guillemin F, Miny J, Kaminsky MC, Mercier M, et al. Responsiveness of EORTC QLQ-C30, QLQ-CR38 and FACT-C quality of life questionnaires in patients with colorectal cancer. Health Qual Life Outcomes. 2011;9(1):70–9.CrossRefPubMedCentralPubMed
41.
Wan C, Yang Z, Tang X, Zou T, Chen D, Zhang D, et al. Development and validation of the system of quality of life instruments for cancer patients: breast cancer (QLICP-BR). Support Care Cancer. 2009;17:359–66.CrossRefPubMed
42.
Wu J, Hu L, Zhang G, Liang Q, Meng Q, Wan C. Development and validation of the nasopharyngeal cancer scale among the system of quality of life instruments for cancer patients (QLICP-NA V2.0): combined classical test theory and generalizability theory. Qual Life Res. 2016;25:2087–100.CrossRefPubMed
43.
Hong JH, Jeon SS, Lee HM, Choi YH, Kim S, Choi HY. The functional assessment of Cancer therapy-prostate (FACT-P) scales in men with prostate cancer: reliability and validity of the Korean version. J Korean Med Sci. 2006;21(2):295–9.CrossRefPubMedCentralPubMed
44.
Rohan EA, Boehm JE, Degroff A, Glover-Kudon R, Preissle J. Implementing the CDC’s colorectal Cancer screening demonstration program: wisdom from the field. Cancer. 2013;119(Suppl 15):2870–83.CrossRefPubMed
45.
Terwee CB, Dekker FW, Wiersinga WM, Prummel MF, Bossuyt PM. On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation. Qual Life Res. 2003;12:349–62.CrossRefPubMed
Metadata
Title
Validation of Quality of Life Instruments for Cancer Patients – Colorectal Cancer (QLICP-CR) in patients with colorectal cancer in Northeast China
Authors
Min Liu
Wei Sun
Yuan-Yi Cai
Hua-Zhang Wu
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-5135-6

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue

Research article

The impact of introducing tyrosine kinase inhibitors on chronic myeloid leukemia survival: a population-based study

Case report

Unusual bilateral ovarian metastases from ileal gastrointestinal stromal tumor (GIST): a case report

Research article

The impact of the social environment on Zambian cervical cancer prevention practices

Research article

Predominance of triple wild-type and IGF2R mutations in mucosal melanomas

Research article

Improved effects of honokiol on temozolomide-induced autophagy and apoptosis of drug-sensitive and -tolerant glioma cells

Research article

Regulation of pancreatic stellate cell activation by Notch3
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits